441
Views
5
CrossRef citations to date
0
Altmetric
Review

Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients: a clinically focused review

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 129-138 | Received 15 Sep 2019, Accepted 23 Jan 2020, Published online: 06 Feb 2020

References

  • Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–114.
  • Shirazian S, Radhakrishnan J. Gastrointestinal disorders and renal failure: exploring the connection. Nat Rev Nephrol. 2010;6(8):480–492.
  • Chong VH. Impact of duration of hemodialysis on gastrointestinal symptoms in patients with end stage renal failure. J Gastrointestin Liver Dis. 2010;19:462–463.
  • Abu Farsakh NA, Roweily E, Rababaa M, et al. Brief report: evaluation of the upper gastrointestinal tract in uraemic patients undergoing haemodialysis. Nephrol Dial Transplant. 1996;11(5):847–850.
  • Bossola M, Tazza L, Giungi S, et al. Anorexia in hemodialysis patients: an update. Kidney Int. 2006;70(3):417–422.
  • Carrero JJ, Aguilera A, Stenvinkel P, et al. Appetite disorders in uremia. J Ren Nutr. 2008;18(1):107–113.
  • Bossola M, Luciani G, Rosa F, et al. Appetite and gastrointestinal symptoms in chronic hemodialysis patients. J Ren Nutr. 2011;21(6):448–454.
  • Chong VH, Tan J. Prevalence of gastrointestinal and psychosomatic symptoms among Asian patients undergoing regular hemodialysis. Nephrology (Carlton). 2013;18(2):97–103.
  • Locke GR, 3rd, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17(1):29–34.
  • Rocco MV, Gassman JJ, Wang SR, et al. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1997;29(6):888–896.
  • Hubalewska A, Stompór T, Płaczkiewicz E, et al. Evaluation of gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis using 99mTc-solid meal. Nucl Med Rev Cent East Eur. 2004;7(1):27–30.
  • De Schoenmakere G, Vanholder R, Rottey S, et al. Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol Dial Transplant. 2001;16(9):1850–1855.
  • Strid H, Simren M, Stotzer PO, et al. Delay in gastric emptying in patients with chronic renal failure. Scand J Gastroenterol. 2004;39(6):516–520.
  • Lee YC, Hung SY, Wang HH, et al. Different risk of common gastrointestinal disease between groups undergoing hemodialysis or peritoneal dialysis or with non-end stage renal disease: a nationwide population-based cohort study. Medicine (Baltimore). 2015;94(36):e1482.
  • Zhang X, Bansal N, Go AS, et al. Gastrointestinal symptoms, inflammation and hypoalbuminemia in chronic kidney disease patients: a cross-sectional study. BMC Nephrol. 2015;16(1):211.
  • Cano AE, Neil AK, Kang JY, et al. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterology. 2007;102(9):1990–1997.
  • Strid H, Simren M, Johansson AC, et al. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant. 2002;17(8):1434–1439.
  • Min F, Tarlo SM, Bargman J, et al. Prevalence and causes of cough in chronic dialysis patients: a comparison between hemodialysis and peritoneal dialysis patients. Adv Perit Dial. 2000;16:129–133.
  • Van V, Schoonjans RS, Struijk DG, et al. Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit Dial Int. 2002;22(1):32–38.
  • Strid H, Fjell A, Simrén M, et al. Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure. Eur J Gastroenterol Hepatol. 2009;21:137–142.
  • Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1989;32(3):151–159.
  • Bjornsson ES, Urbanavicius V, Eliasson B, et al. Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol. 1994;29:1096–1104.
  • Strid H, Simren M, Bjornsson ES. Overuse of acid suppressant drugs in patients with chronic renal failure. Nephrol Dial Transplant. 2003;18(3):570–575.
  • Loudin M, Anderson S, Schlansky B. Bleeding ‘downhill’ esophageal varices associated with benign superior vena cava obstruction: case report and literature review. BMC Gastroenterol. 2016;16(1):134.
  • Blam ME, Kobrin S, Siegelman ES, et al. Downhill” esophageal varices as an iatrogenic complication of upper extremity hemodialysis access. Am J Gastroenterol. 2002;97:216–218.
  • Chandra A, Tso R, Cynamon J, et al. Massive upper GI bleeding in a long-term hemodialysis patient. Chest. 2005;128(3):1868–1868, 1870–1873.
  • Van Vlem B, Schoonjans R, Vanholder R, et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis. 2000;36(5):962–968.
  • Keshavarzian A, Iber FL. Gastrointestinal involvement in insulin-requiring diabetes mellitus. J Clin Gastroenterol. 1987;9(6):685–692.
  • McNamee PT, Moore GW, McGeown MG, et al. Gastric emptying in chronic renal failure. Br Med J (Clin Res Ed). 1985;291(6491):310–311.
  • Thomas R, Panackal C, John M, et al. Gastrointestinal complications in patients with chronic kidney disease–a 5-year retrospective study from a tertiary referral center. Ren Fail. 2013;35(1):49–55.
  • Garrow D, Delegge MH. Risk factors for gastrointestinal ulcer disease in the US population. Dig Dis Sci. 2010;55(1):66–72.
  • Gold CH, Morley JE, Viljoen M, et al. Gastric acid secretion and serum gastrin levels in patients with chronic renal failure on regular hemodialysis. Nephron. 1980;25(2):92–95.
  • Muto S, Murayama N, Asano Y, et al. Hypergastrinemia and achlorhydria in chronic renal failure. Nephron. 1985;40(2):143–148.
  • El Ghonaimy E, Barsoum R, Soliman M, et al. Serum gastrin in chronic renal failure: morphological and physiological correlations. Nephron. 1985;39(2):86–94.
  • Paronen I, Ala-Kaila K, Rantala I, et al. Gastric parietal, chief, and G-cell densities in chronic renal failure. Scand J Gastroenterol. 1991;26(7):696–700.
  • Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728–738.
  • Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367.
  • Sugimoto M, Yamaoka Y. Review of Helicobacter pylori infection and chronic renal failure. Ther Apher Dial. 2011;15(1):1–9.
  • Sugimoto M, Sakai K, Kita M, et al. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2009;75(1):96–103.
  • Chang SS, Hu HY. Lower Helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease. J Chin Med Assoc. 2014;77(7):354–359.
  • Yano T, Yamamoto H, Sunada K, et al. Endoscopic classification of vascular lesions of the small intestine (with videos). Gastrointest Endosc. 2008;67(1):169–172.
  • Clouse RE, Costigan DJ, Mills BA, et al. Angiodysplasia as a cause of upper gastrointestinal bleeding. Arch Intern Med. 1985;145(3):458–461.
  • Kalman RS, Pedrosa MC. Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient. Semin Dial. 2015;28(1):68–74.
  • Navab F, Masters P, Subramani R, et al. Angiodysplasia in patients with renal insufficiency. Am J Gastroenterol. 1989;84(10):1297–1301.
  • Chalasani N, Cotsonis G, Wilcox CM. Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol. 1996;91(11):2329–2332.
  • Zuckerman GR, Cornette GL, Clouse RE, et al. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med. 1985;102(5):588–592.
  • Holden RM, Harman GJ, Wang M, et al. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3(1):105–110.
  • Huang KW, Leu HB, Luo JC, et al. Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis. Dig Dis Sci. 2014;59(4):807–813.
  • Luo JC, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ. 2011;183(18):E1345–1351.
  • Luo JC, Leu HB, Hou MC, et al. Nonpeptic ulcer, nonvariceal gastrointestinal bleeding in hemodialysis patients. Am J Med. 2013;126:264.e225–232.
  • Saeed F, Agrawal N, Greenberg E, et al. Lower gastrointestinal bleeding in chronic hemodialysis patients. Int J Nephrol. 2011;2011:1–8.
  • Wasse H, Gillen DL, Ball AM, et al. Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int. 2003;64(4):1455–1461.
  • Sood P, Kumar G, Nanchal R, et al. Chronic kidney disease and end-stage renal disease predict higher risk of mortality in patients with primary upper gastrointestinal bleeding. Am J Nephrol. 2012;35(3):216–224.
  • Cheung J, Yu A, LaBossiere J, et al. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc. 2010;71(1):44–49.
  • Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38(3):316–321.
  • Parasa S, Navaneethan U, Sridhar AR, et al. End-stage renal disease is associated with worse outcomes in hospitalized patients with peptic ulcer bleeding. Gastrointest Endosc. 2013;77(4):609–616.
  • Lip GY. Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. Am J Med. 2011;124:111–114.
  • Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093–1100.
  • Palmer SC, Di Micco L, Razavian M, et al. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;156(6):445–459.
  • Dahal K, Kunwar S, Rijal J, et al. Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies. Chest. 2016;149(4):951–959.
  • Ishigami J, Grams ME, Naik RP, et al. Chronic kidney disease and risk for gastrointestinal bleeding in the community: the Atherosclerosis Risk in Communities (ARIC) Study. Clin J Am Soc Nephrol. 2016;11(10):1735–1743.
  • Hsu CH, Hu HY, Huang N, et al. Early eradication has a lower risk of peptic ulcer bleeding in Helicobacter pylori-infected chronic kidney disease patients. Eur J Intern Med. 2016;33:112–117.
  • Song YR, Kim HJ, Kim JK, et al. Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis. WJG. 2015;21(16):4919–4924.
  • Shiotani A, Sakakibara T, Yamanaka Y, et al. Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol. 2009;44(2):126–131.
  • Chou CY, Wang SM, Chang PH, et al. Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis. Int J Clin Pract. 2015;69(7):722–728.
  • Bammens B, Evenepoel P, Verbeke K, et al. Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. Am J Clin Nutr. 2004;80(6):1536–1543.
  • Aguilera A, Bajo MA, Espinoza M, et al. Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. Am J Kidney Dis. 2003;42(4):787–796.
  • Grant CJ, Harrison LE, Hoad CL, et al. Patients with chronic kidney disease have abnormal upper gastro-intestinal tract digestive function: a study of uremic enteropathy. J Gastroenterol Hepatol. 2017;32(2):372–377.
  • Ohmori T, Konishi H, Nakamura S, et al. Abnormalities of the small intestine detected by capsule endoscopy in hemodialysis patients. Intern Med. 2012;51(12):1455–1460.
  • Tatar G, Elsurer R, Simsek H, et al. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci. 2004;49(9):1479–1484.
  • Sahin I, Eminbeyli L, Andic S, et al. Screening for celiac disease among patients with chronic kidney disease. Ren Fail. 2012;34(5):545–549.
  • Pahl MV, Vaziri ND. The chronic kidney disease - colonic axis. Semin Dial. 2015;28(5):459–463.
  • Vaziri ND, Yuan J, Rahimi A, et al. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant. 2012;27(7):2686–2693.
  • Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–670.
  • Sabatino A, Regolisti G, Brusasco I, et al. Alterations of intestinal barrier and microbiota in chronic kidney disease. Nephrol Dial Transplant. 2015;30(6):924–933.
  • Evenepoel P, Meijers BK, Bammens BR, et al. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl. 2009;76:S12–S19.
  • Lau WL, Kalantar-Zadeh K, Vaziri ND. The gut as a source of inflammation in chronic kidney disease. Nephron. 2015;130(2):92–98.
  • Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013;83(2):308–315.
  • Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013;83(6):1010–1016.
  • Mafra D, Lobo JC, Barros AF, et al. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol. 2014;9(3):399–410.
  • Strid H, Simrén M, Stotzer P-O, et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion. 2003;67(3):129–137.
  • Jiang S, Xie S, Lv D, et al. A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek. 2016;109(10):1389–1396.
  • Omrani VF, Fallahi S, Rostami A, et al. Prevalence of intestinal parasite infections and associated clinical symptoms among patients with end-stage renal disease undergoing hemodialysis. Infection. 2015;43(5):537–544.
  • Eddi R, Malik MN, Shakov R, et al. Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton). 2010;15(4):471–475.
  • Pardi DS. Recurrent Clostridium difficile infection: an immunodeficiency state?. Clin Gastroenterol Hepatol. 2007;5(6):672–673.
  • Aronsson B, Barany P, Nord CE, et al. Clostridium difficile-associated diarrhoea in uremic patients. Eur J Clin Microbiol. 1987;6(3):352–356.
  • Keddis MT, Khanna S, Noheria A, et al. Clostridium difficile infection in patients with chronic kidney disease. Mayo Clin Proc. 2012;87(11):1046–1053.
  • Kim SC, Seo MY, Lee JY, et al. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Korean J Intern Med. 2015;31(1):125–133.
  • Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int. 2015;88(5):958–966.
  • Gupta J, Mitra N, Kanetsky PA. et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012;7(12):1938–1946.
  • Wu MJ, Chang CS, Cheng CH, et al. Colonic transit time in long-term dialysis patients. Am J Kidney Dis. 2004;44(2):322–327.
  • Yasuda G, Shibata K, Takizawa T, et al. Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients. Am J Kidney Dis. 2002;39(6):1292–1299.
  • Salmoirago-Blotcher E, Crawford S, Jackson E, et al. Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med. 2011;124(8):714–723.
  • Kubota Y, Iso H, Tamakoshi A. Bowel movement frequency, laxative use, and mortality from coronary heart disease and stroke among japanese men and women: the Japan Collaborative Cohort (JACC) Study. J Epidemiol. 2016;26(5):242–248.
  • Sumida K, Molnar MZ, Potukuchi PK, et al. Constipation and Incident CKD. J Am Soc Nephrol. 2017;28(4):1248–1258.
  • Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
  • Lekawanvijit S, Kompa AR, Wang BH, et al. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. Circ Res. 2012;111(11):1470–1483.
  • Vikenes K, Farstad M, Nordrehaug JE. Serotonin is associated with coronary artery disease and cardiac events. Circulation. 1999;100(5):483–489.
  • Costedio MM, Coates MD, Brooks EM, et al. Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation. Am J Gastroenterol. 2010;105(5):1173–1180.
  • Alvarez L, Puleo J, Balint JA. Investigation of gastrointestinal bleeding in patients with end stage renal disease. Am J Gastroenterol. 1993;88(1):30–33.
  • Flobert C, Cellier C, Berger A, et al. Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol. 2000;95(1):195–198.
  • Yu CC, Hsu HJ, Wu IW, et al. Factors associated with mortality from non-occlusive mesenteric ischemia in dialysis patients. Ren Fail. 2009;31(9):802–806.
  • John AS, Tuerff SD, Kerstein MD. Nonocclusive mesenteric infarction in hemodialysis patients. J Am Coll Surg. 2000;190(1):84–88.
  • Archodovassilis F, Lagoudiannakis EE, Tsekouras DK, et al. Nonocclusive mesenteric ischemia: a lethal complication in peritoneal dialysis patients. Perit Dial Int. 2007;27(2):136–141.
  • Newman LA, Mittman N, Hunt Z, et al. Survival among chronic renal failure patients requiring major abdominal surgery. J Am Coll Surg. 1999;188(3):310–314.
  • Li SY, Chen YT, Chen TJ, et al. Mesenteric ischemia in patients with end-stage renal disease: a nationwide longitudinal study. Am J Nephrol. 2012;35(6):491–497.
  • O’Donnell D, Hurst PE. Appendicitis in hemodialysis patients. Nephron. 1989;52:364.
  • Yang CY, Chuang CL, Shen SH, et al. Appendicitis in a CAPD patient: a diagnostic challenge. Perit Dial Int. 2007;27(5):591–593.
  • Chao PW, Ou SM, Chen YT, et al. Acute appendicitis in patients with end-stage renal disease. J Gastrointest Surg. 2012;16(10):1940–1946.
  • Chang SS, Huang N, Hu HY. Patients with end-stage renal disease were at an increased risk of hospitalization for acute diverticulitis. Medicine (Baltimore). 2016;95(39):e4881.
  • Scheff RT, Zuckerman G, Harter H, et al. Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. Ann Intern Med. 1980;92(2_Part_1):202–204.
  • Gluhovschi G, Petrica L, Sporea I, et al. Chronic kidney disease–chronic liver disease. An immunologic cross-talk. Rom J Intern Med. 2015;53:3–12.
  • Jang HR, Kang D, Sinn DH, et al. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. Sci Rep. 2018;8(1):4718–4718.
  • Jin K, Norris K, Vaziri ND. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dial Transplant. 2013;28(2):313–320.
  • Canavese C, Bergamo D, Ciccone G, et al. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients. Kidney Int. 2004;65(3):1091–1098.
  • Fishbane S, Miyawaki N, Masani N. Hepatic iron in hemodialysis patients. Kidney Int. 2004;66(4):1714–1715.
  • Cintin C, Joffe P. Nephrogenic ascites. Case report and review of the literature. Scand J Urol Nephrol. 1994;28(3):311–314.
  • Rodriguez HJ, Walls J, Slatopolsky E, et al. Recurrent ascites following peritoneal dialysis. A new syndrome? Arch Intern Med. 1974;134(2):283–287.
  • Hammond TC, Takiyyuddin MA. Nephrogenic ascites: a poorly understood syndrome. J Am Soc Nephrol. 1994;5(5):1173–1177.
  • Kazama JJ, Kazama S, Koda R, et al. The risk of gallbladder stone formation is increased in patients with predialysis chronic kidney disease but not those undergoing chronic hemodialysis therapy. Nephron Clin Pract. 2009;111(3):c167–172.
  • Vaziri ND, Dure-Smith B, Miller R, et al. Pancreatic pathology in chronic dialysis patients–an autopsy study of 78 cases. Nephron. 1987;46(4):347–349.
  • Rutsky EA, Robards M, Van Dyke JA, et al. Acute pancreatitis in patients with end-stage renal disease without transplantation. Arch Intern Med. 1986;146(9):1741–1745.
  • Quraishi ER, Goel S, Gupta M, et al. Acute pancreatitis in patients on chronic peritoneal dialysis: an increased risk? Am J Gastroenterology. 2005;100(10):2288–2293.
  • Lankisch PG, Weber-Dany B, Maisonneuve P, et al. Frequency and severity of acute pancreatitis in chronic dialysis patients. Nephrol Dial Transplant. 2007;23(4):1401–1405.
  • Bruno MJ, van Westerloo DJ, van Dorp WT, et al. Acute pancreatitis in peritoneal dialysis and haemodialysis: risk, clinical course, outcome, and possible aetiology. Gut. 2000;46(3):385–389.
  • Gupta A, Yuan ZY, Balaskas EV, et al. CAPD and pancreatitis: no connection. Perit Dial Int. 1992;12(3):309–316.
  • Collen MJ, Ansher AF, Chapman AB, et al. Serum amylase in patients with renal insufficiency and renal failure. Am J Gastroenterol. 1990;85(10):1377–1380.
  • Vaziri ND, Chang D, Malekpour A, et al. Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis. Am J Gastroenterol. 1988;83(4):410–412.
  • Shibasaki T, Matsuda H, Ohno I, et al. Significance of serum lipase in patients undergoing hemodialysis. Am J Nephrol. 1996;16(4):309–314.
  • Schoenicke G, Grabensee B, Plum J. Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity. Nephrol Dial Transplant. 2002;17(11):1988–1992.
  • Manga F, Lim CS, Mangena L, et al. Acute pancreatitis in peritoneal dialysis: a case report with literature review. Eur J Gastroenterol Hepatol. 2012;24(1):95–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.